[1] Makedonas G, Betts MR. Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection[J]. Springer Semin Immunopathol, 2006, 28(3):209-219.
[2] 李丽, 吴长有. 多功能T 细胞的检测及其意义[J]. 中国免疫学杂志, 2009, 25 (2): 99-102.
[3] De Rosa SC, Herzenberg LA, Herzenberg LA, et al. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity [J]. Nat Med, 2001, 7 (2):245-248.
[4] 吴长有. 初始和记忆T 细胞的研究进展[J]. 现代免疫学, 2005, 25 (5): 353-356.
[5] Betts MR, Nason MC, West SM, et al. HIV non-progressors preferentially maintain highly functional HIV-specific CD8(+) T cells [J]. Blood, 2006,107 (12): 4781-4789.
[6] Gómez CE, Perdiguero B, Garcia-Arriaza J, et al. Poxvirus vectors as HIV/AIDS vaccines in humans[J]. Hum Vaccin Immunother, 2012, 8 (9):1192-1207.
[7] Barnaba V. Tuning cross-presentation of apoptotic T cells in immunopathology[J]. Adv Exp Med Biol, 2013, 785:27-35.
[8] Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system [J]. Nat Rev Immunol, 2004, 4 (8): 648-655.
[9] Darrah PA, Patel DT, De Luca PM, et al. Multi-functional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major [J]. Nat Med, 2007, 13 (7): 843-850.
[10] Precopio ML, Betts MR, Parrino J, et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses [J]. J Exp Med, 2007, 204 (6): 1405-1416.
[11] Kannanganat S, Ibegbu C, Chennareddi L, et al. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells [J]. J Virol, 2007, 81 (16): 8468-8476.
[12] Reece WH, Pinder M, Gothard PK, et al. A CD4(+) T cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease [J]. Nat Med, 2004, 10 (4): 406-410.
[13] Basu Roy R, Whittaker E, Kampmann B. Current understanding of the immune response to tuberculosis in children[J]. Curr Opin Infect Dis, 2012, 25(3):250-257.
[14] Yu H, Jiang X, Shen C, et al. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4(+) T cells[J]. Infect Immun, 2010, 78(5): 2272-2282.
[15] Sauzullo I, Mengoni F, Marocco R, et al. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis [J]. Br J Dermatol, 2013, 169(5):1133-1140.
[16] Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation [J]. J Immunol Methods, 2003, 281 (1-2): 65-78.
[17] Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection [J]. J Virol, 2001, 75 (24): 11983-11991.
[18] Palladino C, Briz V, Bellón JM, et al. Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique[J]. PLoS One, 2013, 8(12):e82718.
[19] Tully G, Kortsik C, Höhn H, et al. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection [J]. J Immunol, 2005, 174 (4): 2174-2184.
[20] Brookes RH, Pathan AA, McShane H, et al. CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages [J]. Eur J Immunol, 2003, 33 (12): 3293-3302.
[21] Wilkinson KA, Wilkinson RJ, Pathan A, et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis [J]. Clin Infect Dis, 2005, 40 (1): 184-187.
[22] Lammas DA, De Heer E, Edgar JD, et al. Hetero-geneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway [J]. Int J Exp Pathol, 2002, 83 (1): 1-20.
[23] Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent [J]. N Engl J Med, 2001, 345 (15): 1098-1104.
[24] Kalsdorf B, Scriba TJ, Wood K, et al. HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria [J]. Am J Respir Crit Care Med, 2009, 180 (12): 1262-1270.
[25] Caccamo N, Guggino G, Joosten SA, et al. Multi-functional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection [J]. Eur J Immunol, 2010, 40 (8): 2211-2220.
[26] Beveridge NE, Price DA, Casazza JP, et al. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis -specific CD4+ memory T lymphocyte populations [J]. Eur J Immunol, 2007, 37 (11): 3089-3100.
[27] Emu B, Sinclair E, Favre D, et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment [J]. J Virol, 2005,79 (22): 14169-14178.
[28] Iyasere C, Tilton JC, Johnson AJ, et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2 [J]. J Virol, 2003, 77 (20): 10900-10909.
[29] Duvall MG, Precopio ML, Ambrozak DA, et al. Polyfunctional T cell responses are a hallmark of HIV-2 infection [J]. Eur J Immunol, 2008, 38 (2): 350-363.
[30] Ding ZC, Zhou G. Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects[J]. Clin Dev Immunol, 2012,2012: 890178.